Watch Ticker

Verastem, Inc.

Go to Verastem, Inc. Website

$5.96

-0.12 (-1.97%)

Live

Previous Close

$6.08

Day Range

$5.82 - $6.095

Previous Day Range

$5.8801 - $6.33

Market Cap

$334.1 million USD

Day Vol.

1.1 million

Previous Day Vol.

2.0 million

Currency

USD

Primary Exchange

Nasdaq

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote ca...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds

Despite regulatory challenges and budget cuts, the oncology market is projected to reach US$900 billion by 2034, with several biotech companies advancing innovative cancer therapies and demonstrating promising clinical trial results.

Related tickers: ONCY, CUE, VSTM, ALLO, CATX.

Read Full Article

Prnewswire - Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge

The global cancer market is projected to surpass $900 billion by 2034, driven by advancements in cancer treatments from biotech companies like Oncolytics Biotech, Exelixis, Cardiff Oncology, ALX Oncology, and Verastem.

Related tickers: ONCY, EXEL, CRDF, ALXO, VSTM.

Read Full Article

Trending Tickers

Please sign in to view